Ad
Tuesday, 27 December 2016
Sanofi sues Novo Nordisk over diabetes drugs in the U.S.
PARIS/NEW YORK (Reuters) - France's Sanofi has filed a lawsuit in the United States accusing Novo Nordisk of falsely claiming that Sanofi insulin drugs would no longer be available for many U.S. patients so it could promote its competing drug.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment